Date published: 2026-4-29

1-800-457-3801

SCBT Portrait Logo
Seach Input

caspase-12 Inhibitors

Caspase-12 inhibitors constitute a class of small molecules that are specifically designed to modulate the activity of caspase-12, an enzyme primarily associated with endoplasmic reticulum (ER) stress-induced apoptosis. Caspases are a family of cysteine proteases that play a crucial role in the regulation of cell death processes. Among them, caspase-12 stands out for its involvement in the ER stress response, where it is activated upon the accumulation of misfolded proteins in the ER, triggering apoptosis. Caspase-12 inhibitors are developed to interact with the active site of the enzyme, thereby preventing its proteolytic activity and subsequent downstream apoptotic signaling pathways. The chemical structures of caspase-12 inhibitors vary, but they often share common features that allow them to effectively bind to the active site of the enzyme. These inhibitors typically possess functional groups that interact with specific amino acid residues within the caspase-12 active site, facilitating strong and selective binding. The goal of these inhibitors is to competitively occupy the active site, displacing the substrate and preventing the enzymatic cleavage events that lead to apoptosis. Some inhibitors are designed with specificity in mind, targeting only caspase-12 without interfering with the activity of other caspase family members. The rational design of caspase-12 inhibitors involves computational modeling, structure-activity relationship studies, and chemical synthesis to optimize binding affinity and selectivity. In conclusion, caspase-12 inhibitors constitute a chemical class tailored to modulate the enzymatic activity of caspase-12, a pivotal player in ER stress-induced apoptosis. These inhibitors are strategically designed to interact with the active site of caspase-12, disrupting its proteolytic function and interfering with apoptotic signaling pathways. The development of these inhibitors involves careful consideration of the enzyme's active site structure and chemical properties, aiming to achieve potent and selective inhibition.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Z-VAD-FMK

187389-52-2sc-3067
500 µg
$75.00
256
(6)

This is a broad-spectrum caspase inhibitor that inhibits various caspases including caspase-It acts by irreversibly binding to the active site of the enzyme.

Caspase-1 Inhibitor II

178603-78-6sc-300323
sc-300323A
5 mg
25 mg
$260.00
$1248.00
7
(1)

Although originally developed as a caspase-1 inhibitor, it has been reported to also inhibit caspase-12.

ALLM (Calpain Inhibitor)

136632-32-1sc-201268
sc-201268A
5 mg
25 mg
$143.00
$388.00
23
(1)

While primarily a calpain inhibitor, it has been shown to indirectly inhibit caspase-12 activity in certain contexts.

Chloroquine

54-05-7sc-507304
250 mg
$69.00
2
(0)

Chloroquine has been investigated for its potential to inhibit caspase-12 activation and subsequent cell death in certain disease models.